Takeda Pharmaceutical Co Ltd (TKPHF) Other Non Operating Income (2017 - 2019)
Takeda Pharmaceutical (TKPHF) posted quarterly Other Non Operating Income of $246.2 million for Q2 2026, up 6.64% year-over-year from $230.8 million in Q2 2025, and little changed quarter-over-quarter from $245.5 million in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) Other Non Operating Income (2017 - 2019) Analysis & Trends
Takeda Pharmaceutical's Other Non Operating Income history runs 10 years deep, the most recent figure standing at $246.2 million for Q2 2026.
- In Q2 2026, Other Non Operating Income rose 6.64% year-over-year to $246.2 million; the TTM figure through Jun 2026 stood at $986.9 million (down 12.11% YoY), while the FY2026 annual figure was $972.5 million, down 9.4% from the prior year.
- Other Non Operating Income for Q2 2026 stood at $246.2 million, roughly flat from $245.5 million in the prior quarter.
- The five-year high for Other Non Operating Income was $431.3 million in Q3 2024, with the low at -$250.2 million in Q1 2023.
- The 5-year median for Other Non Operating Income is $245.8 million (2026), against an average of $194.4 million.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income slumped 182.71% in 2022, then jumped 672.85% in 2023.
- Takeda Pharmaceutical's Other Non Operating Income stood at $269.5 million in 2022, then increased by 12.42% to $302.9 million in 2023, then slipped by 16.22% to $253.8 million in 2024, then decreased by 8.45% to $232.3 million in 2025, then increased by 5.95% to $246.2 million in 2026.
- Business Quant data shows TKPHF's Other Non Operating Income at $246.2 million in Q2 2026, $245.5 million in Q1 2026, and $232.3 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -164.65 Mn |
| Dec 31, 2018 | -154.00 Mn |
| Dec 31, 2017 | 1.82 Mn |